Answer
Efficacy of Jentadueto (linagliptin + metformin) was not established in a clinical trial in children aged 10–17 years, and treatment of children and adolescents with linagliptin is therefore not recommended.
Sources for this answer
- Jentadueto 2.5 mg/850 mg and 2.5 mg/1,000 mg film-coated tabletsBoehringer Ingelheim Limited · emc · SmPC §4.2 Posology and method of administration · Version 24Document updated
Sources checked